This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Diabetes Mellitus, Type 2
and you are
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

This is a prospective, multi-center, open-label, non-interventional, 12-week study in people with type 2 diabetes mellitus who are treated with recombinant human insulin-SciLin N, SciLin R and SciLin M30 (alone or in combination) in routine clinical practice. The term study insulins will be used in this protocol for these drugs and combinations.

Provided treatments

  • Drug: Insulin (Scilin N, BAY81-9924)
  • Drug: Insulin (Scilin R _BAY81-9924
  • Drug: Insulin(Scilin M30_BAY81-9924)

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01588639. The sponsor of the trial is Bayer and it is looking for 2683 volunteers for the current phase.
Official trial title:
A Prospective Multi-centre, Non-randomized, Open-label, Non-interventional Study to Evaluate the Safety, Efficacy and Injection Compliance of Scilin N, Scilin R or Scilin M30 in Chinese Type 2 Diabetes Mellitus (T2DM)